Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary Study "ACCESS"
Recruiting
Phase N/A Results N/ASummary of Purpose
The purpose of this study is to determine the effect of two novel interventions; (1) a value-based formulary which eliminates copayment for selected high-value medications (proven to prevent heart attacks, stroke, and hospitalizations); and (2) a comprehensive patient education program aimed at lifestyle modification and optimal drug use, combined with relay of information on medication use, on the risk of...
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 24 October 2017.
1 Nov 2015 | 27 Aug 2015 | 1 Apr 2021 | 1 Jan 2022 | 1 Oct 2017 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Design
- Allocation: Randomized
- Masking: Single Blind (Outcomes Assessor)
- Purpose: Prevention
- Intervention: Factorial Assignment
Contacts
- Braden Manns, MD, FRCPC, MSc
braden.manns@albertahealthservices.ca 403-944-2595
- Braden Manns, MD, MSc
braden.manns@albertahealthservices.ca 403-944-2595
View Trial Locations
Recruitment
- Enrollment: 4,714
- Gender: All
- Minimum Age: 65 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country
Principal Investigator
- Braden Manns
University of Calgary